SonALAsense Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
SonALAsense is a clinical-stage biotechnology company based in Oakland, California. It is developing aminolevulinic acid (ALA)-based sonodynamic therapy, a non-invasive drug-device approach for recurrent glioblastoma multiforme (rGBM) and other deadly cancers. The therapy combines MRI-guided focused ultrasound with a drug to selectively target and destroy tumor cells. The company has collaborated with Insightec and the Ivy Brain Tumor Center to test and adapt this approach for glioblastoma, with additional academic and industry partnerships. These collaborations illustrate the company's engagement in biotechnology research as it explores non-invasive cancer therapies.